Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Alpaugh, RK' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 16 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. von Mehren, M; Arlen, P; Gulley, J; Rogatko, A; Cooper, HS; Meropol, NJ; Alpaugh, RK; Davey, M; McLaughlin, S; Beard, MT; Tsang, KY; Schlom, J; Weiner, LM
      The influence of granulocyte macrophage colony-stimulating factor and prior chemotherapy on the immunological response to a vaccine (ALVAC-CEA B7.1) in patients with metastatic carcinoma

      CLINICAL CANCER RESEARCH
    2. Adams, GP; Schier, R; McCall, AM; Simmons, HH; Horak, EM; Alpaugh, RK; Marks, JD; Weiner, LM
      High affinity restricts the localization and tumor penetration of single-chain Fv antibody molecules

      CANCER RESEARCH
    3. Amoroso, AR; Alpaugh, RK; Barth, MW; McCall, AM; Weiner, LM
      Production and characterization of mice transgenic for the A and B isoforms of human Fc gamma RIII

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    4. Alpaugh, RK; von Mehren, M; Palazzo, I; Atkins, MB; Sparano, JA; Schuchter, L; Weiner, LM; Dutcher, JP
      Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon

      MEDICAL ONCOLOGY
    5. ALPAUGH RK; SCHULTZ J; MCALEER C; GIANTONIO BJ; PERSSON R; BURNITE M; NIELSEN SE; VITEK L; PERSSON B; WEINER LM
      SUPERANTIGEN-TARGETED THERAPY - PHASE-I ESCALATING REPEAT DOSE TRIAL OF THE FUSION PROTEIN PNU-214565 IN PATIENTS WITH ADVANCED GASTROINTESTINAL MALIGNANCIES

      Clinical cancer research
    6. ALPAUGH RK; WEINER LM; PERSSON R; PERSSON B
      OVERVIEW OF CLINICAL-TRIALS EMPLOYING ANTIBODY-TARGETED SUPERANTIGENS

      Advanced drug delivery reviews
    7. GIANTONIO BJ; ALPAUGH RK; SCHULTZ J; MCALEER C; NEWTON DW; SHANNON B; GUEDEZ Y; KOTB M; VITEK L; PERSSON R; GUNNARSSON PO; KALLAND T; DOHLSTEN M; PERSSON B; WEINER LM
      SUPERANTIGEN-BASED IMMUNOTHERAPY - A PHASE-I TRIAL OF PNU-214565, A MONOCLONAL-ANTIBODY STAPHYLOCOCCAL-ENTEROTOXIN A RECOMBINANT FUSION PROTEIN, IN ADVANCED PANCREATIC AND COLORECTAL-CANCER

      Journal of clinical oncology
    8. WEINER LM; ALPAUGH RK; VONMEHREN M
      REDIRECTED CELLULAR CYTOTOXICITY EMPLOYING BISPECIFIC ANTIBODIES AND OTHER MULTIFUNCTIONAL BINDING-PROTEINS

      Cancer immunology and immunotherapy
    9. CLARK JI; ALPAUGH RK; VONMEHREN M; SCHULTZ J; GRALOW JR; CHEEVER MA; RING DB; WEINER LM
      INDUCTION OF MULTIPLE ANTI-C-ERB-2 SPECIFICITIES ACCOMPANIES A CLASSICAL IDIOTYPIC CASCADE FOLLOWING 2B1 BISPECIFIC MONOCLONAL-ANTIBODY TREATMENT

      Cancer immunology and immunotherapy
    10. WEINER LM; ALPAUGH RK; AMOROSO AR; ADAMS GP; RING DB; BARTH MW
      HUMAN NEUTROPHIL INTERACTIONS OF A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING TUMOR AND HUMAN FC-GAMMA-RIII

      Cancer immunology and immunotherapy
    11. AMOROSO AR; CLARK JI; LITWIN S; HSIEHMA S; SHI T; ALPAUGH RK; ADAMS GP; WOLF EJ; RING DB; WEINER LM
      BINDING CHARACTERISTICS AND ANTITUMOR PROPERTIES OF 1A10 BISPECIFIC ANTIBODY RECOGNIZING GP40 AND HUMAN TRANSFERRIN RECEPTOR

      Cancer research
    12. MUNN DH; BREE AG; BEALL AC; KAVIANI MD; SABIO H; SCHAUB RG; ALPAUGH RK; WEINER LM; GOLDMAN SJ
      RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR IN NONHUMAN-PRIMATES - SELECTIVE EXPANSION OF A CD16(-KILLER-CELLS() MONOCYTE SUBSETWITH PHENOTYPIC SIMILARITY TO PRIMATE NATURAL)

      Blood
    13. WEINER LM; CLARK JI; DAVEY M; LI WS; DEPALAZZO IG; RING DB; ALPAUGH RK
      PHASE-I TRIAL OF 2B1, A BISPECIFIC MONOCLONAL-ANTIBODY TARGETING C-ERBB-2 AND FC-GAMMA-RIII

      Cancer research
    14. SALEH MN; GOLDMAN SJ; LOBUGLIO AF; BEALL AC; SABIO H; MCCORD MC; MINASIAN L; ALPAUGH RK; WEINER LM; MUNN DH
      CD16(- SPONTANEOUS ELEVATION AND PHARMACOLOGICAL INDUCTION BY RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR() MONOCYTES IN PATIENTS WITH CANCER )

      Blood
    15. WEINER LM; LI W; HOLMES M; CATALANO RB; DOVNARSKY M; PADAVIC K; ALPAUGH RK
      PHASE-I TRIAL OF RECOMBINANT MACROPHAGE-COLONY-STIMULATING FACTOR ANDRECOMBINANT GAMMA-INTERFERON - TOXICITY, MONOCYTOSIS, AND CLINICAL EFFECTS

      Cancer research
    16. WEINER LM; HOLMES M; RICHESON A; GODWIN A; ADAMS GP; HSIEHMA ST; RING DB; ALPAUGH RK
      BINDING AND CYTOTOXICITY CHARACTERISTICS OF THE BISPECIFIC MURINE MONOCLONAL ANTIBODY-2B1

      The Journal of immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 22:34:26